68Ga/177Lu-NRT6020
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga/177Lu-NRT6020, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients [Phase 1]